CASI Pharmaceuticals
CASI
CASI
50 hedge funds and large institutions have $37.3M invested in CASI Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 52 → 50 (-2)
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.19M | |
| 2 | +$656K | |
| 3 | +$242K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$191K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$127K |
Top Sellers
| 1 | -$661K | |
| 2 | -$208K | |
| 3 | -$145K | |
| 4 |
Renaissance Technologies
New York
|
-$120K |
| 5 |
Goldman Sachs
New York
|
-$48.6K |